CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 6 enrolled
Drug / intervention
Retrospective Case Onlybiological
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02235493
NCT02235493N/ACompleted
CompareCT.gov

A Single-Center, Non-interventional Substudy of ALX-HPP-502 to Assess Functional Natural History Data of Patients With Juvenile Historical Controls in ENB-006-09

Alexion Pharmaceuticals, Inc.·observational·Posted Sep 10, 2014·Updated Mar 13, 2019

In Brief

An observational study evaluating Retrospective Case Only for Hypophosphatasia and Bone Disease. Completed, enrolled 6 participants across 1 site.

Detailed Summary

The purpose of this study is to characterize the natural history of HPP in patients with Juvenile-onset HPP who served as historical controls in ENB-006-09.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsHypophosphatasia, Bone Disease
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
201520162017201820192020202120222023202420252026
First PostedSep 10, 2014
Enrollment StartAug 1, 2014
Primary CompletionSep 1, 2014
TodayJul 2, 2026
Enrollment to primary: 1 monthPosted 11.8 years ago

Interventions

Retrospective Case Onlybiological